Table 1 Overview of measurements
| Â | Instrument | Items | Screening baseline | Before exposure sessions | Weekly at exposure sessions | Post-treament | Follow-up |
|---|---|---|---|---|---|---|---|
SAD | SIAS | 20 | + | + | – | + | + |
Diagnoses | PSE | 140 | + | – | – | – | – |
Cost and efforts required to conduct exposure sessions. | SWEAT | 11 | – | + | + | – | – |
ASD characteristics | SRS-2 | 65 | + | – | – | – | – |
ADHD | ASRS | 18 | + | – | – | – | – |
General functioning | EQ-5D-5 L | 26 | + | + | – | + | + |
Working Alliance Inventory | WAI-SR | 12 | – | – | – | + | – |
Alcohol use | AUDIT | 10 | + | + | – | + | – |
Substance use | DUDIT | 11 | + | + | – | + | – |
Depression | BDI-II | 21 | + | + | – | + | – |